# LAM PHARMACEUTICAL CORP — Form D

LAM PHARMACEUTICAL CORP of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-24. The offering totals $1.0M, of which $172K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2013-10-24
- Form: D
- Accession: 0001071272-13-000005
- Industry: Pharmaceuticals
- Exemptions: 04, 04.1, 04.2, 04.3
- Total offering: $1.0M
- Amount sold: $172K
- Remaining: $828K
- Minimum investment: $17K
- Investors: 1
- Date of first sale: 2013-08-01
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-205333

## Issuer

- Name: LAM PHARMACEUTICAL CORP
- CIK: 0001071272
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 425 University Av. Suite 601, TORONTO, A6, M5G1T6
- Phone: 4166190291

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Pepe Carla | Director | Toronto, A6 |
| John Adams | Executive Officer | Daytona Beach, FL |

## More

- [CIK 1071272 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1071272&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001071272-13-000005.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.